Organon has shared positive results from a long-term extension (LTE) study of its Vtama (tapinarof) cream, 1% in atopic ...

All the key secondary endpoints of the trial were met, demonstrating the “statistical significance” of the therapy.

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...

Results showed that 42.3% of patients given 300-mg rocatinlimab once every four weeks saw at least a 75% reduction from ...

Organon (OGN) announced results from an analysis of the Phase 3 ADORING 3 open-label, long-term extension study evaluating VTAMA cream, 1% once ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

Donkey milk has been cherished for centuries as a natural beauty secret, known for its nourishing and rejuvenating properties ...

Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...

Skin reactions can be alarming, especially when they appear suddenly. Many people struggle to tell the difference between ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...

A break from treatment with Vtama won’t lead to worsening of patients’ atopic dermatitis, finds a new analysis of an ...

Kenvue (KVUE) will share new clinical data demonstrating how its brands are leveraging the latest science to shape the future of the Skin ...